|
|
Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence,
Substance Abuse Treatment Advisory,
Volume 6, Issue 1 |
|
|
|
The Role of Biomarkers in the Treatment of Alcohol Use Disorders,
Substance Abuse Treatment Advisory,
Volume 5, Issue 4 |
|
|
|
Anabolic Steroids,
Substance Abuse Treatment Advisory,
Volume 5, Issue 3 |
|
|
|
Prescription Medications: Misuse, Abuse, Dependence, and Addiction,
Substance Abuse Treatment Advisory,
Volume 5, Issue 2 |
|
|
|
OxyContin®: Prescription Drug Abuse-
2008 Revision,
Substance Abuse Treatment Advisory,
Volume 7, Issue 1 |
|
|
|
Acamprosate: A New Medication for Alcohol Use Disorders,
Substance Abuse Treatment Advisory,
Volume 4, Issue 1 |
|
|
|
Inhalants,
Substance Abuse Treatment Advisory,
Volume 3, Issue 1 |
|
|
|
GHB: A Club Drug To Watch,
Substance Abuse Treatment Advisory,
Volume 2, Issue 1 |
|
|
|
|
Access a wide array of products, including manuals, Treatment
Improvement Protocol (TIP) Series, Technical Assistance
Publications (TAPs), and periodicals.
Knowledge
is powerful only when it is used. Find out what KAP is doing
to help treatment providers adopt and implement the information
in CSAT's published materials.
KAP's
Multi-Language Initiative (MLI) adapts KAP and other Federal
Government publications for clients and the general public
whose first language is not English.
Find resources to improve workforce capacity through online continuing education, retention, training and development in the area of substance abuse treatment.
Access
the latest conference information, databases, and Federal
grant announcements.
Page
Last Updated:
Wednesday, August 27, 2008
|
|